New Methods for Evaluating Preventive Migraine Treatment

Summary

The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatment information provided. Using a clinical within-subjects, balanced placebo design, patients with chronic migraine will receive four treatment conditions in a randomized order.

Timeline

Start

2025-06-19

Primary completion

2028-09

Completion

2028-09

Drugs

Indications